Molecular biology in acute leukemia (Q36585592)

15 August 2017

1 reference

title

Molecular biology in acute leukemia (English)

1 reference

15 August 2017

0 references

2

Dolors Colomer

1 reference

15 August 2017

Mireia Camós

1

1 reference

15 August 2017

publication date

1 August 2006

1 reference

Clinical and Translational Oncology

15 August 2017

published in

1 reference

15 August 2017

volume

8

1 reference

15 August 2017

issue

8

1 reference

15 August 2017

page(s)

550-559

1 reference

Cytoplasmic sequestration of the polyomavirus enhancer binding protein 2 (PEBP2)/core binding factor alpha (CBFalpha) subunit by the leukemia-related PEBP2/CBFbeta-SMMHC fusion protein inhibits PEBP2/CBF-mediated transactivation

15 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12094-006-0060-6

Chromatin remodeling and the maintenance of genome integrity.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12094-006-0060-6

Acute mixed lineage leukemia with an inv(8)(p11q13) resulting in fusion of the genes for MOZ and TIF2.

21 January 2018

1 reference

12 December 2020

In vivo analysis of the molecular genetics of acute promyelocytic leukemia

1 reference

12 December 2020

Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML).

1 reference

12 December 2020

CALM-AF10 is a common fusion transcript in T-ALL and is specific to the TCRgammadelta lineage.

1 reference

12 December 2020

Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia

1 reference

12 December 2020

Inhibition of FLT3 in MLL. Validation of a therapeutic target identified by gene expression based classification

1 reference

12 December 2020

Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia

1 reference

12 December 2020

The inv(16) fusion protein associates with corepressors via a smooth muscle myosin heavy-chain domain

1 reference

12 December 2020

Chromosome abnormalities and MLL rearrangements in acute myeloid leukemia of infants

1 reference

12 December 2020

Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia

1 reference

12 December 2020

FLT3 and MLL intragenic abnormalities in AML reflect a common category of genotoxic stress

1 reference

12 December 2020

Type I MOZ/CBP (MYST3/CREBBP) is the most common chimeric transcript in acute myeloid leukemia with t(8;16)(p11;p13) translocation

1 reference

12 December 2020

Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA)

1 reference

12 December 2020

Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia

1 reference

12 December 2020

Gene expression profiling of acute myeloid leukemia with translocation t(8;16)(p11;p13) and MYST3-CREBBP rearrangement reveals a distinctive signature with a specific pattern of HOX gene expression.

1 reference

12 December 2020

The BCR-ABL story: bench to bedside and back

1 reference

12 December 2020

Block of C/EBP alpha function by phosphorylation in acute myeloid leukemia with FLT3 activating mutations.

1 reference

12 December 2020

Flt3 tandem duplication mutations cooperate with Wnt signaling in leukemic signal transduction.

1 reference

12 December 2020

The RUNX genes: gain or loss of function in cancer

1 reference

12 December 2020

Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation.

1 reference

12 December 2020

Incidence and prognosis of c-KIT and FLT3 mutations in core binding factor (CBF) acute myeloid leukaemias

1 reference

12 December 2020

The rhombotin family of cysteine-rich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13

1 reference

12 December 2020

Overlapping expression of early B-cell factor and basic helix-loop-helix proteins as a mechanism to dictate B-lineage-specific activity of the lambda5 promoter

1 reference

12 December 2020

The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia.

1 reference

12 December 2020

Hox regulation of normal and leukemic hematopoietic stem cells.

1 reference

12 December 2020

Genetics of myeloid malignancies: pathogenetic and clinical implications

1 reference

12 December 2020

Constitutive activation of Akt by Flt3 internal tandem duplications is necessary for increased survival, proliferation, and myeloid transformation.

1 reference

12 December 2020

Cytogenetics and molecular genetics of T-cell acute lymphoblastic leukemia: from thymocyte to lymphoblast

1 reference

12 December 2020

A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia

1 reference

12 December 2020

The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties

1 reference

12 December 2020

Universal inactivation of both p16 and p15 but not downstream components is an essential event in the pathogenesis of T-cell acute lymphoblastic leukemia

1 reference

12 December 2020

Fusion of MOZ and p300 histone acetyltransferases in acute monocytic leukemia with a t(8;22)(p11;q13) chromosome translocation

1 reference

12 December 2020

AML with 11q23/MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases

1 reference

12 December 2020

Molecular genetics of T cell development

1 reference

12 December 2020

The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein

1 reference

12 December 2020

Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia

1 reference

12 December 2020

Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AML

1 reference

12 December 2020

Biologic and clinical significance of the FLT3 transcript level in acute myeloid leukemia

1 reference

12 December 2020

Acute monoblastic leukemia with t(8;16): a distinct clinicopathologic entity; report of a case and review of the literature

1 reference

12 December 2020

Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia

1 reference

12 December 2020

Activation of AML1-mediated transcription by MOZ and inhibition by the MOZ-CBP fusion protein

1 reference

12 December 2020

Clinical importance of cytogenetics in acute myeloid leukaemia

1 reference

12 December 2020

Rearrangements of chromosome band 3q21 in myeloid leukemia.

1 reference

12 December 2020

Gene expression profiling in T-cell acute lymphoblastic leukemia

1 reference

12 December 2020

FLT3 mutations in the activation loop of tyrosine kinase domain are frequently found in infant ALL with MLL rearrangements and pediatric ALL with hyperdiploidy

1 reference

12 December 2020

Acute myeloid leukemia

1 reference

12 December 2020

Comparative analysis of MLL partial tandem duplication and FLT3 internal tandem duplication mutations in 956 adult patients with acute myeloid leukemia

1 reference

12 December 2020

The molecular pathogenesis of acute myeloid leukemia

1 reference

12 December 2020

Acute lymphoblastic leukemia

1 reference

12 December 2020

Fusion of the MORF and CBP genes in acute myeloid leukemia with the t(10;16)(q22;p13)

1 reference

12 December 2020

CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: prognostic relevance and analysis of cooperating mutations

1 reference

12 December 2020

Cytogenetics in acute myeloid leukemia

1 reference

12 December 2020

All patients with the T(11;16)(q23;p13.3) that involves MLL and CBP have treatment-related hematologic disorders

1 reference

12 December 2020

Prognostically useful gene-expression profiles in acute myeloid leukemia.

1 reference

12 December 2020

Molecular genetics of acute lymphoblastic leukemia

1 reference

12 December 2020

TAL1, TAL2 and LYL1: a family of basic helix-loop-helix proteins implicated in T cell acute leukaemia

1 reference

12 December 2020

HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL).

1 reference

12 December 2020

Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling

1 reference

12 December 2020

MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia

1 reference

12 December 2020

Incidence and prognostic value of FLT3 internal tandem duplication and D835 mutations in acute myeloid leukemia

1 reference

12 December 2020

Cytogenetics in acute leukemia

1 reference

12 December 2020

The monocytic leukemia zinc finger protein MOZ is a histone acetyltransferase

1 reference

12 December 2020

Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia

1 reference

12 December 2020

AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia.

1 reference

12 December 2020

Nucleophosmin and cancer

1 reference

12 December 2020

Normal and oncogenic FLT3

1 reference

12 December 2020

CEBPA point mutations in hematological malignancies

1 reference

12 December 2020

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype

1 reference

12 December 2020

Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease

1 reference

12 December 2020

10.1007/S12094-006-0060-6

Identifiers

DOI

1 reference

15 August 2017

1 reference